Natco Pharma gets warning letter from USFDA for Telangana plant : vimarsana.com

The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company's Kothur-based formulation facility.

Related Keywords

Kothur , Karnataka , India , Telangana , Andhra Pradesh , Natco Pharma , Drug Administration , Business , Companies , Usfda ,